The global in-vitro colorectal cancer screening tests market size reached US$ 943 Million in 2022. Looking forward, the publisher expects the market to reach US$ 1,352 Million by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.
2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2023-2028?
3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?
4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?
5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?
6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?
7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?
8. What are the key regions in the global in-vitro colorectal cancer screening tests market?
9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?
In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.
In-Vitro Colorectal Cancer Screening Tests Market Trends:
The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global In-vitro colorectal cancer screening tests market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, imaging type and end user.Breakup by Product:
- Fecal Occult Blood Tests
- Guaiac FOB Stool Test
- Immuno-FOB Agglutination Test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
- Biomarker Tests
- Tumor M2-PK Stool Test
- Transferrin Assays
- CRC DNA Screening Tests
- Methylated Gene Testing
- Panel DNA Tests
Breakup by Imaging Type:
- Colonoscopy
- Proctoscopy
- CT Scan
- Ultrasound
- MRI
- PET Scan
Breakup by End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Breakup by Region:
North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.Key Questions Answered in This Report
1. What was the size of the global in-vitro colorectal cancer screening tests market in 2022?2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2023-2028?
3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?
4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?
5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?
6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?
7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?
8. What are the key regions in the global in-vitro colorectal cancer screening tests market?
9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global In-vitro Colorectal Cancer Screening Tests Market
6 Market Breakup by Product
7 Market Breakup by Imaging Type
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Beckman Coulter Inc. (Danaher Corporation)
- Eiken Chemical Co. Ltd.
- Epigenomics AG
- Exact Sciences Corporation
- Hemosure Inc.
- Immunostics Inc. (Boditech Med Inc.)
- Medline Industries LP
- Merck KGaA
- Qiagen N.V.
- Quest Diagnostics Incorporated
- R-Biopharm AG
- Siemens AG
- Sysmex Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | June 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 943 Million |
| Forecasted Market Value ( USD | $ 1352 Million |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
